These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32699186)

  • 1. Acid Exposure Time > 6% Might Not Improve the Therapeutic Outcome in Chinese Gastroesophageal Reflux Disease Patients.
    Lin Y; Li Y; Liang M; Tan N; Zhang M; Chen S; Xiao Y
    J Neurogastroenterol Motil; 2021 Jan; 27(1):55-62. PubMed ID: 32699186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index Could Identify Gastroesophageal Reflux Disease but pH-Impedance Metrics Alone Might Not Correlate With Proton Pump Inhibitor Response in Chinese Patients With Typical Reflux Symptoms.
    Wang D; Duan C; Zhang X; Xu J; Hou X; Xiang X
    J Neurogastroenterol Motil; 2022 Oct; 28(4):580-588. PubMed ID: 36250365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of adjunctive evidence from MII-pH monitoring and high-resolution manometry in inconclusive GERD patients with AET 4-6.
    Jiang Y; Jiang L; Ye B; Lin L
    Therap Adv Gastroenterol; 2021; 14():17562848211013484. PubMed ID: 34104208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
    Zhang M; Tan N; Li Y; Chen M; Xiao Y
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Salivary Pepsin in the Diagnosis of Gastroesophageal Reflux Disease (GERD) Evaluated Using High-Resolution Manometry and 24-Hour Multichannel Intraluminal Impedance-pH Monitoring.
    Guo Z; Wu Y; Chen J; Zhang S; Zhang C
    Med Sci Monit; 2020 Nov; 26():e927381. PubMed ID: 33220027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern diagnosis of GERD: the Lyon Consensus.
    Gyawali CP; Kahrilas PJ; Savarino E; Zerbib F; Mion F; Smout AJPM; Vaezi M; Sifrim D; Fox MR; Vela MF; Tutuian R; Tack J; Bredenoord AJ; Pandolfino J; Roman S
    Gut; 2018 Jul; 67(7):1351-1362. PubMed ID: 29437910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
    Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics.
    Ribolsi M; Savarino E; Rogers B; Rengarajan A; Coletta MD; Ghisa M; Cicala M; Gyawali CP
    J Neurogastroenterol Motil; 2021 Oct; 27(4):565-573. PubMed ID: 34045366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective ambulatory pH monitoring and subjective symptom assessment of gastroesophageal reflux disease show type of carbohydrate and type of fat matter.
    Gu C; Olszewski T; Vaezi MF; Niswender KD; Silver HJ
    Therap Adv Gastroenterol; 2022; 15():17562848221101289. PubMed ID: 35663436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between gastroesophageal flap valve abnormality and novel parameters in patients with gastroesophageal reflux disease symptoms by the lyon consensus.
    Guo Z; Wu Y; Zhan Y; Zhang C
    Sci Rep; 2021 Jul; 11(1):15076. PubMed ID: 34301972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?
    Tolone S; De Bortoli N; Marabotto E; de Cassan C; Bodini G; Roman S; Furnari M; Savarino V; Docimo L; Savarino E
    Neurogastroenterol Motil; 2015 Oct; 27(10):1423-31. PubMed ID: 26227513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Straight leg raise metrics on high-resolution manometry associate with esophageal reflux burden.
    Rogers BD; Rengarajan A; Ali IA; Hasak SL; Hansalia V; Gyawali CP
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13929. PubMed ID: 32633016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
    Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
    Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Lyon Consensus: Does It Differ From the Previous Ones?
    Ghisa M; Barberio B; Savarino V; Marabotto E; Ribolsi M; Bodini G; Zingone F; Frazzoni M; Savarino E
    J Neurogastroenterol Motil; 2020 Jul; 26(3):311-321. PubMed ID: 32606254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.
    Hasak S; Yadlapati R; Altayar O; Sweis R; Tucker E; Knowles K; Fox M; Pandolfino J; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2912-2919. PubMed ID: 32007543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.